This extensive homogeneity of the driver event is highly remarkable in the light of the ambiguous situation of driver genetic event distribution in other tumor entities: human epidermal growth factor receptor 2 HER2 gene amplification is an accepted driver event in breast cancer development. This evidence concerns the gene ERBB2 and neoplasm.